Clinical practice guidelines and conflict of interest

November 2005
CMAJ: Canadian Medical Association Journal;11/22/2005, Vol. 173 Issue 11, p1297
Academic Journal
Addresses the conflicts of interest linked to the clinical practice guidelines issued by national disease associations. Estimated number of guideline authors financially linked to pharmaceutical companies according to the U.S. National Guideline Clearinghouse; Method use to maintain that such financial conflicts exert no influence on panelists' recommendations; Purpose of national disease associations.


Related Articles

  • Who pays for this conference? Time patients and doctors knew. Vercellini, Paolo; ViganĂ², Paola; Somigliana, Edgardo // BMJ: British Medical Journal;6/14/2014, Vol. 348 Issue 7962, p23 

    A letter to the editor is presented in response to the article "Who Pays This Doctor? It's Time Patients Knew," by M. McCartney in the May 6, 2014 issue.

  • Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry. Choudhry, Niteesh K.; Stelfox, Henry Thomas; Detsky, Allan S. // JAMA: Journal of the American Medical Association;2/6/2002, Vol. 287 Issue 5, p612 

    Presents a study to quantify the extent and nature of interactions between authors of clinical practice guidelines (CPG) and the pharmaceutical industry. Context; Objective; Design, setting, and participants; Main outcome measures; Results; Conclusion that there appears to be interaction...

  • Physicians With Conflicts Of Interest.  // Health Affairs;Apr2012, Vol. 31 Issue 4, p885 

    The article presents a letter to the editor and a response to a Narrative Matters essay in the December 2011 issue, which explores the author's experience of losing her trust in her physician.

  • Pharmaceutical industry and physician relationships explored: Part 2. Bal, B. Sonny; Brenner, Lawrence H. // Orthopedics Today;Dec2011, Vol. 31 Issue 12, p46 

    The article explores the issues associated with the invasion of the right of physicians and surgeons to make independent health care decisions, in relation to pharmaceutical industry-physician relationships.

  • EMA is accused of weakening its conflict of interest policy. Watson, Rory // BMJ: British Medical Journal;12/6/2014, Vol. 349 Issue 7896, pg7431 

    The article reports on the accusation against the European Medicines Agency (EMA) for weakening its rules on conflicts of interest in 2014.

  • Australian campaign aims to stop visits to doctors from drug representatives. Coopes, Amy // BMJ: British Medical Journal;10/18/2014, Vol. 349 Issue 7979, pg6183 

    The article reports on the formal launch of the No Advertising Please campaign at the Royal Australian College of General Practitioners annual conference to be held on October 11, 2014 in Adelaide, South Australia.

  • RESPONSE. Mathieson, Clive; Cresswell, Adam // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;12/3/2011, Vol. 343 Issue 7834, p1151 

    A response by Adam Cresswell to a letter to the editor regarding the publication of the Health of the Nation series in the newspaper "The Australian," which was sponsored by Medicines Australia, is presented.

  • Medicines agency must tighten COI rules for accounts to be approved. Watson, Rory // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/26/2012, Vol. 344 Issue 7858, p6 

    The article reports on the refusal of the European parliament to sign off the financial accounts of the European Medicines Agency for 2010 until the organisation shows that it has effective procedures in place for handling potential conflicts of interest (COI) among its scientific experts.

  • Conflict of Interest, Disclosure, and Trial Reports. Psaty, Bruce M. // JAMA: Journal of the American Medical Association;4/8/2009, Vol. 301 Issue 14, p1477 

    In this article the author discusses conflicts of interest, disclosure and clinical trial reports and the relationship all three have with medical ethics. He is critical of an apparent lack of concern with medical ethics that is often seen within members of the medical community, within the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics